SEC Info
uses JavaScript!
To view pages properly, enable JavaScript in your browser.
SEC Info
℠
Home
Search
My Interests
Help
Sign In
Please
Sign In
BioCardia, Inc.
CA
SEC # 925741
1 Related Registrant:
Same Name: Biocardia Lifesciences, Inc. — 11/4/16 — SEC # 1635886
Click to view...
Registrant
About
Filings
Files
Relationships
Names
Topics
Web
98 Topics
within the
Past Year
Past Two Years
Past Three Years
Past Four Years
Past Five Years
Entire Database
Show:
Most-Recent Document
All Documents
And:
Exhibits
As Of
Filing
Doc.
Page
Title
Docs.
12/6/23
424B5
1
About the Company
1
1
About this Prospectus
2
1
About This Prospectus Supplement
1
3/27/24
10-K
1
Business
1
1
Certain Relationships and Related Transactions, and Director Independence
1
1
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
1
1
Consolidated Balance Sheets
1
1
Consolidated Statements of Cash Flows
1
1
Consolidated Statements of Operations
1
1
Consolidated Statements of Stockholders' Equity (Deficit)
1
1
Controls and Procedures
1
1
Cybersecurity
1
12/6/23
424B5
1
Description of Capital Stock
2
1
Description of Debt Securities
2
1
Description of Depositary Shares
2
1
Description of Purchase Contracts
2
1
Description of Subscription Rights
2
1
Description of Units
2
1
Description of Warrants
2
1
Dilution
1
3/27/24
10-K
1
Directors, Executive Officers and Corporate Governance
1
1
Disclosure Regarding Foreign Jurisdiction that Prevent Inspections
1
12/6/23
424B5
1
Dividend Policy
1
3/27/24
10-K
1
Executive Compensation
1
1
Exhibits, Financial Statement Schedules
1
12/6/23
424B5
1
Experts
2
3/27/24
10-K
1
Financial Statements and Supplementary Data
1
12/6/23
424B5
1
Forward Looking Statements
1
10/20/23
S-3
1
Forward-Looking Statements
1
12/6/23
424B5
1
Incorporation by Reference
2
1
Incorporation of Certain Information by Reference
1
1
Legal Matters
2
3/27/24
10-K
1
Legal Proceedings
1
1
Management's Discussion and Analysis of Financial Condition and Results of Operations
1
1
Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
1
1
Mine Safety Disclosures
1
1
Notes to Consolidated Financial Statements
1
12/6/23
424B5
1
Offering, The
1
3/27/24
10-K
1
Other Information
1
1
Part I
1
1
Part Ii
1
1
Part Iii
1
1
Part Iv
1
1
Patent protection of biotherapeutics is complex and uncertain, The
1
12/6/23
424B5
1
Plan of Distribution
2
3/27/24
S-8
1
Power of Attorney (contained on signature page hereto)
1
2/14/24
S-3
1
Power of Attorney (included on the signature page to this Registration Statement)
2
3/27/24
10-K
1
Power of Attorney (see page 112 of this Annual Report on Form 10-K)
1
1
Principal Accounting Fees and Services
1
1
Properties
1
12/6/23
424B5
1
Prospectus Summary
2
3/27/24
10-K
1
Quantitative and Qualitative Disclosures about Market Risk
1
1
Report of Independent Registered Public Accounting Firm (PCAOB ID # 27 )
1
1
Risk Factors
3
12/6/23
424B5
1
S-1
1
1
S-10
1
1
S-11
1
1
S-2
1
1
S-3
1
1
S-5
1
1
S-6
1
1
S-7
1
1
S-9
1
1
S-ii
1
1
S-iii
1
3/27/24
10-K
1
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
1
1
Selected Financial Data
1
1
Table of Contents
3
12/6/23
424B5
1
The Offering
1
3/27/24
10-K
1
The patent protection of biotherapeutics is complex and uncertain
1
1
Unresolved Staff Comments
1
12/6/23
424B5
1
Use of Proceeds
2
1
Where You Can Find More Information
2
3/27/24
10-K
1
101
1
1
105
1
1
108
1
1
109
1
1
110
1
↑
Top
Copyright © 2024
Fran Finnegan & Company LLC
– All Rights Reserved.
About
—
Privacy
—
Redactions
—
Help
— Thu., May 2, 11:39:39.
2pm ET